



Views of healthcare consumer representatives on defensive practice:  
“We are your biggest advocate and supporter … not the enemy” 
 
ABSTRACT  
Background: The patient-clinician interaction is a site at which defensive practice could occur, when 
clinicians provide tests, procedures, and treatments mainly to reduce perceived legal risks, rather 
than to advance patient care. Defensive practice is a driver of low value care and exposes patients to 
the risks of unnecessary interventions. To date, patient perspectives on defensive practice and its 
impacts on them are largely missing from the literature. This exploratory study conducted in 
Australia aimed to examine the views and experiences of healthcare consumer representatives in 
this under-examined area. 
Methods: Semi-structured interviews were conducted with healthcare consumer representatives 
involved in healthcare consumer advocacy organisations in Australia. Data were transcribed and 
analysed thematically. 
Results: Nine healthcare consumer representatives participated. Most had over 20 years of 
involvement and advocacy in healthcare, including personal experiences as a patient or carer and/or 
formal service roles on committees or complaint bodies for healthcare organisations. Participants 
uniformly viewed defensive practice as having a negative impact on the clinician-patient 
relationship. Themes identified the importance of fostering patient-clinician partnership, effective 
communication and informed decision-making. The themes support a shift from the concept of 
defensive practice to preventive practice in partnership, which focuses on the shared interests of 
patients and clinicians in achieving safe and high value care. 
Conclusion: This Australian study offers healthcare consumers’ perspectives on the impacts of 
defensive practice on patients. The findings highlight the features of clinician-patient partnership 
that will help to improve communication and decision-making, and prevent the defensive provision 
of low value care. 
Patient or Public Contribution: Healthcare consumer representatives were involved as participants 
in this study. 




The patient-clinician interaction is a site at which defensive practice can occur, when clinicians 
provide tests, procedures and referrals to reduce perceived medico-legal risks, such as complaints 
and litigation.1 Clinicians see this practice as legally protective,2 yet it drives low value care of no or 
little benefit.3 Defensive practice falls afoul of ethical obligations by prioritising professionals’ self-
interests over patients’ interests, exposing patients to avoidable harms and misallocating scarce 
healthcare resources.4,5 Patients and clinicians are recognised as important partners in addressing 
low value care,6 and involving patients in initiatives to promote healthcare safety and reduce 
avoidable harms has been described as a “moral imperative.”7(p77) However, clinicians’ anxieties 
about legal risks can undermine this by fuelling “hostile attitudes, such as viewing patients chiefly as 




Empirical research has focused on healthcare professionals who widely report defensive behaviours 
across higher income countries in North America, Europe, the Middle East and Asia Pacific.1,8 
Discussion of ways to reduce defensive practice often focuses on legal reforms,9 yet legislative and 
policy changes targeted at the legal risk environment for clinicians have had, at best, modest impacts 
on defensive practice.10 The growing de-implementation literature urges that “[p]atients are directly 
involved in and impacted by low-value care and may play a pivotal role in solutions to reduce its 
use.”11 Likewise, patients’ experiences and expectations are part of the puzzle in understanding 
defensive practice and optimising the clinician-patient interaction to reduce medico-legal risks and 
low value care.  
However, patient perspectives on defensive practice and its impacts on them are largely missing 
from the literature. A recent Italian study used 1-hour interviews with 5 physicians and 20-minute 
interviews with 15 patients to explore dynamics within the doctor-patient relationship.12 The results 
described four relationship archetypes and the implications for defensive practice. A British study of 
defensive practice in obstetric care appeared to include patient perspectives; the article stated the 
views of three consumer representatives were sought in addition to midwives and medical 
specialists, however, the published data only reported the professionals’ comments.13  
Given the dearth of patient-focused research on defensive practice, we undertook an exploratory 
qualitative study to investigate the perspectives of healthcare consumer representatives in Australia. 
Medical professionals were also interviewed as part of a broader project on defensive practice and 
low value care. Results from doctors’ interviews are reported separately. 
METHOD 
Our methodological description is guided by the Consolidated Criteria for Reporting Qualitative 
Studies (COREQ).14 
Study design 
This study uses a qualitative descriptive design, a suitable method when researchers aim to present 
“straightforward descriptions of experiences and perceptions, particularly in areas where little is 
known about the topic under investigation.”15(p444) The study was approved by the University of 
Technology Sydney Human Research Ethics Committee (Ref No. ETH18-2985). 
Participants 
Healthcare consumer representatives were recruited by invitation notices shared through national 
and state-based healthcare consumer advocacy organisations, such as the Consumers Health Forum 
of Australia.1 These organisations support the aims of Choosing Wisely Australia, a national initiative 
that encourages healthcare organisations and consumer groups to question and reduce unnecessary 
tests, treatments and procedures.2 The invitation defined defensive practice and its connection to 
low value care, and sought insights from consumer representatives, especially those with interests 
or experience in matters related to improving healthcare quality and safety. This convenience 
sampling approach enabled us to reach informants with relevant knowledge and experience in 
relation to the study aim. Interested individuals contacted the research team.  
                                                           
1 See list of healthcare consumer organisations here: https://www.choosingwisely.org.au/members-
supporters/consumer-organisations. While supporters of Choosing Wisely Australia, these organisations are 
independent entities focused on giving a voice to consumers on health issues, especially quality and safety.  





Data collection  
The lead author (N.R.) conducted semi-structured interviews with nine healthcare consumer 
participants in October-November 2019. Eight interviews were conducted by tele- or web-
conference and one person chose to be interviewed in person at a university campus. Interviewees 
gave verbal consent to participate, including consent to audio-recording and transcription. The 
interviews averaged around 60 minutes.  
The interviews explored participants’ views and experiences on the following topics: patient 
awareness of defensive practice; impact of defensive practice on the clinician-patient relationship; 
patient attitudes and expectations; and patient involvement in solutions to defensive practice. At 
the start of the interview, defensive practice was defined as including doctors ordering tests and 
procedures, making referrals and prescribing medication mainly to reduce perceived legal risks, such 
as complaints or lawsuits. 
Data analysis 
Thematic analysis was used to describe and interpret the data.16 Two authors (N.R. and B.J.) 
independently read each transcript to identify the main themes across participants’ responses to the 
four interview topics. This analysis was then compared and discussed and an iterative writing 
process was used to prepare a descriptive account of the themes, remaining intentionally close to 
the participants’ own words, consistent with our qualitative method.17 Exemplar quotations were 
selected to illustrate the main points. The third author (J.J.) reviewed and commented on this 
analysis. All authors participated in interpretation of the results to reflect on their broader 
implications, which informs our discussion of themes in connection with literature on defensive 
practice, medical overuse, and patient-centred care.   
RESULTS 
Interviews were conducted with nine participants, aged from 29 – 70 years. Most (n=6) were aged 
45 – 59 years and reported over 20 years of involvement and advocacy in healthcare. This included 
personal experiences as a patient or carer for a person with chronic illness and formal service roles 
on committees or complaint bodies for healthcare organisations. Eight participants were female, one 
was male, and all reported university degrees. Participants were from six of Australia’s eight states 
and territories. This was an experienced group of informants and, given the specific focus of the 
study on a medico-legal topic, our targeted recruitment strategy through consumer advocacy 
organisations, and the in-depth interviews, adequate informational power for our study aim was 
attained with this sample size.18  
Patient awareness of defensive medical practice 
Participants were of the view that, in general, many patients would not think their doctors provide 
low value care as a form of legal self-protection. One participant stated most patients “think doctors 
do no harm and that they’re experts, and they [patients] want to put their care in the hands of the 
experts.” (P6) Similarly, another participant felt a “majority [of patients] would be surprised” that 
doctors engage in defensive practice, thinking instead that if a test or procedure is ordered, “the 
doctor would do it for health checking, safety reasons, rather than for protection against 
complaints.” (P3)  
Most interviewees had not heard of the specific term ‘defensive practice’, however several reflected 
on their own healthcare experiences and situations they felt were examples of defensive behaviour. 




observations, and consent documents that interviewees felt were written in legalistic language. 
Several interviewees described situations where they advocated for themselves to decline proposed 
tests, treatments or procedures they considered unnecessary (P3, P4, P7, P9): 
“I've rarely had that [wait and see] approach from a medical practitioner or my GP, let's just 
see how it goes. They have been, in the manner of defensive medical practice, keen to do 
something. Before we meet next, we have to have some test or some quantitative number 
to look at ... I myself have been the one normally who has sided with [the approach of] no, 
let's sit back and see how it goes.” (P9) 
“Sometimes the best thing is to say [to the doctor], no thank you, we don’t want that test. 
Or if that's not going to change what you're going to be doing, then don’t do it.”  (P4) 
Impact of defensive practice on the clinician-patient relationship  
Participants uniformly viewed defensive practice as having a negative impact on the clinician-patient 
relationship: “It’s not going to deliver the best health outcome if a doctor feels that they have to 
practice defensively as opposed to practising in the patient’s best interests...” (P2) Practising 
defensively implies “an antagonistic relationship instead of a partnership relationship. … I'm 
concerned that once you have a litigation sort of frame, it’s not really the right frame for a 
therapeutic human relationship.” (P8) Good care is “not about care to a patient, it’s care with a 
patient. It's a very different thing.” (P4)  
Participants called for a partnership involving a sharing of expertise, where the patient is recognised 
as “the expert in themselves … helping them [doctors] do their job … It’s supposed to be 
relationship-based care with two-way respect.” (P6) Several participants (P4, P6, P8, P9) pointed out 
that patients have the biggest stake in their own health and wellbeing; clinicians should recognise 
and build on this as an asset:  
“View your patient [as] the biggest advocate … because who's got the biggest incentive to … 
avoid low quality care and have high value care? Who of anybody in the system, who has the 
most to gain and the absolute most to lose? It’s your patient and [their] family. So, we are 
your biggest advocate and supporter … not the enemy, not the hostile [person] that has to 
be managed … and defensively engaged with. If you communicate well and bring us along 
the journey … to make good, informed decisions … then we will be the biggest supporter 
for” high value care. (P4) 
Participants also commented that defensive practice focuses on legal risk management rather than 
patient safety and clinical best practices: “It's not patient safety at the top [of clinicians’ priorities], 
it's risk at the top so it's not a good thing... Overwhelmingly I can't see that defensive medicine's 
going to have a positive effect, I think it's going to have a negative effect.” (P8) Another participant 
stated: “They [doctors] talk about clinical evidence and the best practice and the needs of the 
individual. I think all of that goes out the window really when [they’re] worried” about legal risks. 
(P1) 
Another interviewee described the difference between a conversation driven by defensiveness and a 
conversation to engage the patient as an informed participant in their own care:  
“That means you [the doctor] work with the level of health literacy with that patient and you 
have a conversation that does require the doctor to explain why they're doing something and 
the thoughts and rationale. Not because they're defensive and trying to cover their butt, but 




outcome, that you have a patient that understands what is happening to them or what the 
recommended treatment is and why, and you’re together working out a plan. (P4) 
Participants expressed concern about the burdens of unnecessary or low value care, including out of 
pocket costs, time demands on patients and their family members or carers, and ongoing worry. In 
the words of one participant, the harms include: “a waste of time, a waste of money … anxiety that 
is still not alleviated by having the tests done, because they are still in that situation where the 
doctors can’t give them an answer as to why they are experiencing the symptoms that they are.” 
(P2)  
Patient attitudes and expectations  
Participants were asked for their views on the role of patient demand and intolerance of uncertainty 
as triggers for defensive practice. Interviewees commented on patient expectations that a medical 
visit will result in “some kind of intervention” (P3), such as a prescription, pathology testing, scans or 
a specialist referral, which may drive low value care. Participants described societal forces that shape 
patients’ attitudes and expectations, including the internet: 
“Consumers are way more informed and misinformed than what they were many years ago. 
… Through social media they are bombarded with stuff. There’s always stories about 
someone who ended up being really ill or died … because they weren’t diagnosed. I think 
consumers nowadays are bombarded with it, so there is a problem with people thinking that 
the least little thing means something terrible.” (P2) 
This factor is intensified by a cultural expectation of “instant gratification … wanting an instant 
answer” (P6), which can also influence health professionals’ attitudes: doctors “think most people 
turn up, it’s easier to give them a script, they probably want a script.” (P7) Several participants (P2, 
P3, P5, P9) elaborated on additional health system drivers of low value care, including financial 
incentives for healthcare providers and a perceived proliferation and fragmentation of healthcare 
services. For example, one participant commented on practitioner over-supply as a driver of 
unnecessary interventions: “surgeons sitting around doing nothing who want to cut your knee 
open…” (P9) Another participant recounted experiences where allied health professionals 
recommended interventions that medical professionals did not endorse and commented: “There 
needs to be consistency across the messaging and the explanations from all of the [providers] that a 
consumer is dealing with for their health condition.” (P2)  
Participants commented that doctors have a responsibility to inform and educate patients and to 
address unrealistic or inappropriate expectations. Doctors who defensively give patients low value 
care were seen as reinforcing skewed expectations that a medical visit will culminate in an order for 
pathology testing, a specialist referral or a prescription. One participant made an analogy: “It's a 
little bit like a parent having spoilt a child … then just going, ‘Well this child, I can't manage their 
expectations.’” (P8) This participant urged doctors “to build that trust [with patients] and have those 
conversations about why they're not going to do things – it's not fun and it’s not easy – but again I 
would contend it's part of the much needed process of [encouraging] higher health literacy in our 
population.” (P8)  
It was also suggested that these conversations need to address diagnostic uncertainty, a situation 
that can provoke defensive practice. One participant noted that being upfront about the harms of 




“sometimes waiting and seeing … [and having] uncertainty might be the best course of 
action so that we don’t put you through unnecessary testing … because it could just make 
things even more grey. … We could actually cause you more harm [including] psychological 
harm and not actually change how we would be treating the symptoms that you have.” (P4)  
Openness about uncertainty can provide peace of mind for patients: “We can sleep at night and 
know we’re fully informed and all on the same page, accepting the risks because of that open, 
honest, transparent conversation that wasn’t defensive.” (P4) It is also “an investment in health 
literacy that will actually pay off. You're going to have an informed patient.” (P4) Building a 
relationship through effective communication also reduces doctors’ legal risks; one interviewee 
commented “the more relationship-based care that they [doctors] offer, that not only are there 
better outcomes for the patient, but the less chance of being sued.” (P6)   
Consumer involvement in solutions to defensive practice  
As experienced healthcare consumers, participants described practical strategies to ensure clinical 
encounters are effective, efficient and support the development of a therapeutic partnership that 
avoids defensive provision of low value care. Suggested strategies included preparing a plan for the 
conversation with the doctor, including a diary or summary of symptoms/concerns and any care 
received from other practitioners. This approach “means you have a much better dialogue and you 
actually talk about the most important thing.” (P4) Several participants (P1, P4, P6) said they check 
online health record systems (e.g., in Australia, the ‘My Health Record’ system) to ensure 
information is up to date and accurate. For complex health concerns, booking a longer appointment 
or two appointments to allow time to reflect on information, were other strategies that participants 
valued.  
While describing their own development as empowered and proactive healthcare consumers, 
participants noted some patients may not have the knowledge, confidence or skills needed to 
support that kind of relationship:  
“It comes back to how much knowledge the consumer has to lend to the discussion … [to] 
have a better conversation with your GP, better relationship in assessing this [low value 
care]. But I tend to think a lot of consumers don’t. They just take what they're offered, from 
the experts so to speak.” (P9)  
Participants also noted that medical appointments can be stressful, especially when patients are 
unwell or in pain, and this hinders effective communication and patient recall (P3, P5, P7, P8). They 
agreed written resources help to improve the quality of the discussion, including a list of question 
prompts to discuss with the care provider, patient-oriented brochures and websites, and the 
clinician providing a brief written summary for the patient: “the doctor makes dot points about what 
the problem is, and if there's no intervention, the last dot point will be, what to do if there is no 
change or it gets worse.” (P3)  
To support patient education and health literacy, several participants (P4, P7, P8) advocated for new 
or expanded practitioner roles, such as nurse-led clinics and health educator roles:  
“I firmly believe there are new roles in our health system that will start to emerge that will 
help provide better patient outcomes and better patient experiences that don’t currently 
exist … an investment in new and expanded roles ... would be significantly cheaper than your 
heavily educated, long-term trained doctor or even nurse that should start to evolve in the 




The opposing view was that this is core to doctors’ role: “if doctors really are engaging, practising 
and improving their communication … that's probably a better strategy [than] involving another 
clinician” or new role. (P3) 
Several participants (P1, P4, P7, P8, P9) recommended peer supporter or advocate roles, especially 
to help people with complex conditions navigate healthcare systems:  
“I don't think there's any substitute for the peer and somebody who's had that disease who 
can talk people through what the options really are … sharing the power, sharing the 
expertise … [like] somebody having a diagnosis of cancer and being with somebody who's 
been cancer free for 10 years with the same cancer but [who] knows exactly what it feels 
like when you are facing all those tests and treatment…” (P8) 
Participants discussed the importance of processes to raise concerns or make complaints. These 
were perceived as opportunities for learning and improvement: “It's disappointing that complaints 
are seen in such a negative way [by practitioners] because complaints of course are the bedrock of 
quality and safety improvements.” (P8) However, processes need to be fair, transparent and open, 
and ensure both patients and doctors are supported, such as via access to a peer support person. 
From a patient perspective, participants described desirable outcomes from complaint processes, 
including: practitioners taking responsibility for identified problems and not trying to deflect blame; 
apologies; and follow-up information about steps taken to ensure similar problems do not occur in 
the future:  
“Unless it’s a major, major problem, I think a lot of the time you just want an apology … and 
you don’t want it to happen to somebody else.” (P7)  
“I have no way of knowing whether anything that we asked for [in complaint resolution 
meetings] has ever happened. … They said they would do it, but I have no way of knowing. … 
I think if there could be more … open communication and discussion and … feedback to the 
patient about … what's changed.” (P1)  
Several participants (P2, P6, P8) also commented on broader strategies to support health literacy in 
communities and ensure consumers have access to high quality, reliable information. Suggestions 
included more transparent reporting of safety, quality and performance data from healthcare 
organisations and stronger regulation of sources of health misinformation. 
DISCUSSION 
Current literature on reducing medical overuse calls for patient-centred approaches, recognising the 
clinician-patient interaction is where decisions to engage in or avoid low value care are made.6,11 
Legal defensiveness is a factor in this interaction and clinicians’ anxieties about medico-legal risks 
can stymie efforts to reduce unnecessary tests and procedures. For example, some clinicians 
perceive that following professionally-developed guidelines to reduce low value care will increase 
patient complaints or other legal risks.19,20 However, defensive practice can invite such problems by 
exposing patients to the harms of low value interventions.4 Defensive practice pursues false 
reassurance and induces a ‘more is better’ mindset that drives overdiagnosis and overtreatment.21 It 
diverts the clinical consultation to tests and treatments and shirks conversations about options that 
may include tolerating a period of uncertainty to wait and see how symptoms evolve. The 
cumulative effect is to diminish patient trust.22(p168)  
The healthcare consumer perspectives from this study reinforce these critiques. Participants 




relationship. The findings add to the dialogue on patient-centred approaches in the de-
implementation of low value care. In particular, the themes support a shift from the concept of 
defensive practice to preventive practice (see Figure 1), which seeks to prevent patient 
dissatisfaction, complaints and litigation by fostering partnership, communication and informed 
decision-making. Preventive practice focuses on the shared interests of patients and healthcare 
professionals in order to co-produce safe and high value care.12,23  
[Insert Figure 1] 
Partnership 
Our participants emphasised the importance of a therapeutic partnership between clinicians and 
patients. The findings resonate with the concept of the ‘expert’ or ‘involved’ patient, which 
recognises patients’ expertise in their own life circumstances, body, symptoms, values, goals and risk 
tolerances.24,25 Education and support to build patients’ health literacy and confidence can enable 
“active engagement and empowerment of patients in the planning and provision of their care,” 
especially when living with a chronic condition.26(p2617) However, health professionals’ views on the 
‘involved’ patient vary; one clinician may consider such a patient as confident, informed and 
resourceful, while another may see warning signs of a potential litigant: “the demanding patient, the 
unreasonable patient, the time consuming patient, or the patient who knows it all.”27(p723)  
But from a legal and ethical perspective, patient involvement in informed decision-making is vital. 
The extent of the involvement needs to be tailored to the preferences and ability of the individual 
patient.28,29 As our participants noted, patients’ stake in their own health should be recognised as an 
asset to develop to improve engagement and outcomes. Batalden et al highlight how this asset-
focused approach supports an effective patient-clinician partnership23 and Sutton et al observe: 
“Patients can become experts in their own conditions, are highly motivated to ensure a good 
outcome, and are the only people who are present at all stages during the provision of care...”7(p77)  
Moreover, the relationship between clinicians and patients rests on a foundation of informed 
decision-making, meaning patients need comprehensible information to make choices about their 
care. Authoritative court rulings and professional codes of conduct emphasise these points.30 For 
example, the Medical Board of Australia’s professional code for doctors states: “Relationships based 
on respect, openness, trust and good communication will support you to work in partnership with 
your patients.”31 Deficiencies in these relationship dimensions are commonly at the root of patient 
dissatisfaction and complaints,32,33 so a focus on building relationships will do more to reduce 
medico-legal risks than the defensive provision of low value tests and treatments. 
Effective communication, questioning low value care and managing uncertainty 
Effective communication within the clinician-patient relationship is key to preventive practice, as it 
overcomes flaws in consent processes34 and facilitates patients’ rights to make informed choices. 
Importantly, effective conversations and decision-making must take account of the risks of tests and 
procedures, including emotional, financial and physical burdens. Both patients and clinicians are 
influenced by cognitive biases that focus attention on rare but devastating reports of delayed 
diagnoses, which leads to unnecessary tests and treatments.35,36 Evidence of the harms of overuse 
and patient stories of these harms may help to shift these biases3,35 and ensure clinicians and 
patients have “a clear understanding of all the downsides of overuse [in order to] contribute fully to 




Our study participants reflected on the factors that influence a ‘more is better’ mindset, recognising 
that patient ‘demand’ does not simply come into being but originates within a social ecology. 
Providing low value care – motivated by legal defensiveness, acquiescence to inappropriate requests 
or other drivers – reinforces biases toward medical overuse. Prior research indicates mismatches 
between expectations and preferences of patients and perceptions of clinicians. For example, 
“clinicians often perceive patient demand where it does not exist,” or that patients value a 
prescription or procedure more than a discussion to explain, advise and reassure.37(p280) Our 
participants placed value on open conversations about care options, including the option of watchful 
waiting, and how to manage the uncertainty of unexplained symptoms. Similarly, participants in an 
American study of public views on low value care “expected that spending less time ordering and 
reading tests would allow clinicians more time to talk with their patients … [and] encourage 
discussion of the benefits and limitations of each approach and greater acknowledgment of clinical 
uncertainty.”38  
Clinicians may justify defensive practices as being of some therapeutic value to patients by assuaging 
their anxiety.36,39 However, our findings underscore that diagnostic investigations can make patients’ 
situations ‘even more grey’ by inducing anxiety rather than providing reassurance, particularly for 
patients with a low probability of having a serious illness.40,41 Reassurance may instead be achieved 
through a multi-step process of communication and trust-building, where the rationale, risks and 
potential benefits of tests or procedures are discussed, and the clinician actively listens to and 
acknowledges the patient’s concerns.42,43 Our participants offered practical suggestions for high 
quality, time-efficient conversations and safety netting practices so patients know what to do if their 
symptoms persist or worsen.44 An informed ‘wait and see’ approach strikes “a middle ground 
between immediate acquiescence [to low value care] and flat denial of requests, consistent in spirit 
with the broader, patient-centered communication paradigm.”45  
Building patients’ knowledge and confidence to be involved in their care, understand their options 
and make informed decisions, does not just have to be the task of time-pressed clinicians. Patient-
targeted educational resources, decision aids and peer supporters can strengthen health literacy, 
provide reassurance, and support informed and shared decision-making to help avoid overuse.11,46 
Beyond the clinical relationship context, well-designed public information campaigns can assist in 
improving health literacy and raising awareness of low value care.47 Tackling the pernicious impacts 
of health-related mis- and disinformation, particularly disseminated through online sources, may 
require further intervention through consumer protection regulation and enforcement.48,49  
Safe and high value care   
A preventive practice approach prioritises patient safety and seeks to avoid the risks of low value 
tests, treatments and procedures. Our participants noted that avenues for patients to raise concerns 
or make complaints are valuable to support safety and quality improvements. Managing these 
processes effectively is important in meeting the needs and expectations of patients and reducing 
negative impacts for clinicians. In particular, doctors report that poor experiences in complaint 
processes heighten their medico-legal anxieties, which drives their propensity to engage in future 
defensive practice.50  
Research on healthcare consumers’ views and experiences in relation to adverse events and 
complaint processes identifies the importance of open communication, apologies, corrective actions 
and follow-up with consumers to explain patient safety outcomes.51,52 Our findings reinforce these 
points. As a component of preventive practice, timely and effective disclosures and apologies can 




highlighted defensive attitudes and blame-oriented cultures as barriers to desired communication 
and responses to adverse events.55 Facilitators for optimal practices included training for clinicians 
and organisational changes to promote cultures of openness and transparency. These 
recommendations are equally salient to support a shift from defensive to preventive practice. 
Limitations 
The informants for this study were experienced healthcare consumers with patient advocacy 
perspectives. A limitation of our convenience sample is that they were mainly female, with 
university education, high English language fluency and strong health literacy. Their views may differ 
from less experienced patients with lower levels of education and health literacy. The sample size 
was small but adequate to provide informational power for our exploratory qualitative study, in line 
with contemporary research methods guidance.18,56 Our findings reflect consumer experiences in a 
high income, Western country.  
Opportunities for research 
This study begins to fill a gap in understanding healthcare consumer perspectives on defensive 
practice, its impact on the clinician-patient relationship and its contribution to low value care.  
Shared themes were clear from the data and offer insights from the perspectives of consumers who 
have experienced a journey of becoming actively engaged in their own care, as well as in advocacy 
roles. Given the key theme of relationships based on partnership, future research is recommended 
that jointly involves clinicians and patients to better understand their attitudes, behaviours and 
preferences in relation to defensive and preventive practices. Co-design approaches will provide 
opportunites for partnering with patients in research activities.57 
Purposive sampling in future research is recommended to gain perspectives from participants with 
diverse characteristics and experiences, such as patients from culturally and linguistically diverse 
backgrounds, patients with varying levels of education and health literacy, and patients receiving 
care in different settings (eg, general practice, emergency departments). 
Low value care is recognised as a global problem, but limited research investigates defensive 
practice in middle- and low-income countries.58,59 Future research would be beneficial to understand 
clinician and patient experiences beyond those that have largely been studied in higher income 
countries.  
CONCLUSION  
Despite its reported prevalence, defensive practice is not in patients’ interests and involves 
behaviours that can increase, rather than reduce, medico-legal risks.4,5 Our study adds the views of 
healthcare consumers who articulated the negative impacts on patients. Indeed, patient 
perspectives have challenged “traditional tort reform advocacy [that] pits consumers and providers 
against each other as if we were enemies.”60(p22) Likewise, our participants emphasised the features 
of clinician-patient partnership that will help to improve communication and decision-making, as 
well as prevent the defensive provision of low value tests and treatments. Efforts to support patient 
involvement in their care are “often viewed as challenging, time-consuming, and potentially costly” 
however, Sypes et al’s analysis showed “the ensuant reductions in low-value care make tackling 
these challenges worthwhile.”11(p11) In turn, reducing low value care can also reduce medico-legal 
risks. Instead of defensive practice, preventive practice aligns the values and interests of clinicians 






1.  Ries NM, Jansen J. Physicians’ Views and Experiences of Defensive Medicine: An International 
Review of Empirical Research. Health Policy. Published online February 26, 2021. 
doi:10.1016/j.healthpol.2021.02.005 
2.  Kachalia A, Mello MM. Defensive Medicine—Legally Necessary but Ethically Wrong?: Inpatient 
Stress Testing for Chest Pain in Low-Risk Patients. JAMA Internal Medicine. 2013;173(12):1056-
1057. 
3.  Brownlee SM, Korenstein D. Better understanding the downsides of low value healthcare could 
reduce harm. BMJ. 2021;372:n117. doi:10.1136/bmj.n117 
4.  Bester JC. Defensive practice is indefensible: how defensive medicine runs counter to the 
ethical and professional obligations of clinicians. Med Health Care and Philos. 2020;23(3):413-
420. doi:10.1007/s11019-020-09950-7 
5.  Healey B, Kopen D, Smith J. Physicians, Defensive Medicine and Ethics. Academy of Health Care 
Management Journal. 2011;7(1):59-78. 
6.  Morgan DJ, Leppin AL, Smith CD, Korenstein D. A Practical Framework for Understanding and 
Reducing Medical Overuse: Conceptualizing Overuse Through the Patient-Clinician Interaction. 
J Hosp Med. 2017;12(5):346-351. doi:10.12788/jhm.2738 
7.  Sutton E, Eborall H, Martin G. Patient Involvement in Patient Safety: Current experiences, 
insights from the wider literature, promising opportunities? Public Management Review. 
2015;17(1):72-89. doi:10.1080/14719037.2014.881538 
8.  Rinaldi C, D’Alleva A, Leigheb F, et al. Defensive practices among non-medical health 
professionals: An overview of the scientific literature. Journal of Healthcare Quality Research. 
2019;34(2):97-108. doi:10.1016/j.jhqr.2018.12.005 
9.  Kapp MB. Defensive medicine: No wonder policymakers are confused. International Journal of 
Risk & Safety in Medicine. 2016;28(4):213-219. doi:10.3233/JRS-170733 
10.  Agarwal R, Gupta A, Gupta S. The impact of tort reform on defensive medicine, quality of care, 
and physician supply: A systematic review. Health Services Research. 2019;54(4):851-859. 
doi:10.1111/1475-6773.13157 
11.  Sypes EE, de Grood C, Whalen-Browne L, et al. Engaging patients in de-implementation 
interventions to reduce low-value clinical care: a systematic review and meta-analysis. BMC 
Medicine. 2020;18(1):116. doi:10.1186/s12916-020-01567-0 
12.  Riotta S, Bruccoleri M. Revisiting the patient–physician relationship under the lens of value co-
creation and defensive medicine. Journal of Service Theory and Practice. 2021;ahead-of-
print(ahead-of-print). doi:10.1108/JSTP-06-2020-0142 
13.  Symon A. Litigation and changes in professional behaviour: a qualitative appraisal. Midwifery. 
2000;16(1):15-21. doi:10.1054/midw.1999.0193 
14.  Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 





15.  Doyle L, McCabe C, Keogh B, Brady A, McCann M. An overview of the qualitative descriptive 
design within nursing research. Journal of Research in Nursing. 2020;25(5):443-455. 
16.  Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 
2006;3(2):77-101. doi:10.1191/1478088706qp063oa 
17.  Kim H, Sefcik JS, Bradway C. Characteristics of Qualitative Descriptive Studies: A Systematic 
Review. Res Nurs Health. 2017;40(1):23-42. doi:10.1002/nur.21768 
18.  Malterud K, Siersma VD, Guassora AD. Sample Size in Qualitative Interview Studies: Guided by 
Information Power. Qual Health Res. 2016;26(13):1753-1760. doi:10.1177/1049732315617444 
19.  Calder LA, Neilson HK, Whyte EM, Ji J, Bhatia RS. Medico-Legal Cases Involving Cardiologists 
and Cardiac Test Underuse or Overuse. CJC Open. 2021;3(4):434-441. 
doi:10.1016/j.cjco.2020.11.018 
20.  Chan T, Judkins S. Choosing Wisely for Doctors: A Survey on Attitudes, Perceived Barriers and 
Enablers. Presented at the: Choosing Wisely Australia National Meeting; May 30, 2018; 
Canberra, Australia. 
21.  Pathirana T, Clark J, Moynihan R. Mapping the drivers of overdiagnosis to potential solutions. 
BMJ. 2017;358:j3879. doi:10.1136/bmj.j3879 
22.  Garattini L, Padula A. Defensive medicine in Europe: a ‘full circle’? Eur J Health Econ. 
2020;21(2):165-170. doi:10.1007/s10198-019-01144-0 
23.  Batalden M, Batalden P, Margolis P, et al. Coproduction of healthcare service. BMJ Qual Saf. 
2016;25(7):509-517. doi:10.1136/bmjqs-2015-004315 
24.  Shaw J, Baker M. “Expert patient”-dream or nightmare? BMJ : British Medical Journal. 
2004;328(7442). doi:http://dx.doi.org.ezproxy.lib.uts.edu.au/10.1136/bmj.328.7442.723 
25.  Buljac-Samardzic M, Clark MA, van Exel NJobA, van Wijngaarden JDH. Patients as team 
members: Factors affecting involvement in treatment decisions from the perspective of 
patients with a chronic condition. Health Expectations. 2021;n/a(n/a). doi:10.1111/hex.13358 
26.  Phillips RL, Short A, Kenning A, et al. Achieving patient-centred care: the potential and 
challenge of the patient-as-professional role. Health Expectations. 2015;18(6):2616-2628. 
doi:https://doi.org/10.1111/hex.12234 
27.  Shaw J, Baker M. “Expert patient”—dream or nightmare? BMJ. 2004;328(7442):723-724. 
doi:10.1136/bmj.328.7442.723 
28.  Fisher KA, Tan ASL, Matlock DD, Saver B, Mazor KM, Pieterse AH. Keeping the patient in the 
center: Common challenges in the practice of shared decision making. Patient Educ Couns. 
2018;101(12):2195-2201. doi:10.1016/j.pec.2018.08.007 
29.  Cribb A, Entwistle VA. Shared decision making: trade‐offs between narrower and broader 
conceptions. Health Expect. 2011;14(2):210-219. doi:10.1111/j.1369-7625.2011.00694.x 
30.  Chan SW, Tulloch E, Cooper ES, Smith A, Wojcik W, Norman JE. Montgomery and informed 




31.  Medical Board of Australia. Good medical practice: a code of conduct for doctors in Australia. 
Accessed May 27, 2021. https://www.medicalboard.gov.au/codes-guidelines-policies/code-of-
conduct.aspx 
32.  Bismark MM, Spittal MJ, Gurrin LC, Ward M, Studdert DM. Identification of doctors at risk of 
recurrent complaints: a national study of healthcare complaints in Australia. BMJ Quality & 
Safety. 2013;22(7):532-540. doi:10.1136/bmjqs-2012-001691 
33.  Mattarozzi K, Sfrisi F, Caniglia F, De Palma A, Martoni M. What patients’ complaints and praise 
tell the health practitioner: implications for health care quality. A qualitative research study. 
International Journal for Quality in Health Care. 2017;29(1):83-89. doi:10.1093/intqhc/mzw139 
34.  Hall DE, Prochazka AV, Fink AS. Informed consent for clinical treatment. CMAJ. 
2012;184(5):533-540. doi:10.1503/cmaj.112120 
35.  Scott IA, McPhail SM. Sociocognitive approach to behaviour change for reducing low-value 
care. Aust Health Review. 2020;45(2):173-177. doi:10.1071/AH20209 
36.  Michiels-Corsten M, Donner-Banzhoff N. Beyond accuracy: hidden motives in diagnostic 
testing. Family Practice. 2018;35(2):222-227. doi:10.1093/fampra/cmx089 
37.  Kohut MR, Keller SC, Linder JA, et al. The inconvincible patient: how clinicians perceive demand 
for antibiotics in the outpatient setting. Family Practice. 2020;37(2):276-282. 
doi:10.1093/fampra/cmz066 
38.  Schlesinger M, Grob R. Treating, Fast and Slow: Americans’ Understanding of and Responses to 
Low-Value Care. The Milbank Quarterly. 2017;95(1):70-116. doi:10.1111/1468-0009.12246 
39.  Klingman D, Localio AR, Sugarman J, et al. Measuring Defensive Medicine Using Clinical 
Scenario Surveys. J Health Polit Policy Law. 1996;21(2):185-220. doi:10.1215/03616878-21-2-
185 
40.  van Ravesteijn H, van Dijk I, Darmon D, et al. The reassuring value of diagnostic tests: A 
systematic review. Patient Education and Counseling. 2012;86(1):3-8. 
doi:10.1016/j.pec.2011.02.003 
41.  Rolfe A, Burton C. Reassurance after diagnostic testing with a low pretest probability of serious 
disease: systematic review and meta-analysis. JAMA Intern Med. 2013;173(6):407-416. 
doi:10.1001/jamainternmed.2013.2762 
42.  Ferry AV, Strachan FE, Stewart SD, et al. Exploring Patient Experience of Chest Pain Before and 
After Implementation of an Early Rule-Out Pathway for Myocardial Infarction: A Qualitative 
Study. Annals of Emergency Medicine. 2020;75(4):502-513. 
doi:10.1016/j.annemergmed.2019.11.012 
43.  Giroldi E, Veldhuijzen W, Leijten C, et al. “No need to worry”: an exploration of general 
practitioners’ reassuring strategies. BMC Family Practice. 2014;15:133. 
doi:http://dx.doi.org.ezproxy.lib.uts.edu.au/10.1186/1471-2296-15-133 
44.  Jones D, Dunn L, Watt I, Macleod U. Safety netting for primary care: evidence from a literature 




45.  Jerant A, Fenton JJ, Kravitz RL, et al. Association of Clinician Denial of Patient Requests With 
Patient Satisfaction. JAMA Internal Medicine. 2018;178(1):85-91. 
doi:10.1001/jamainternmed.2017.6611 
46.  Muscat DM, Shepherd HL, Nutbeam D, Trevena L, McCaffery KJ. Health Literacy and Shared 
Decision-making: Exploring the Relationship to Enable Meaningful Patient Engagement in 
Healthcare. J Gen Intern Med. 2021;36(2):521-524. doi:10.1007/s11606-020-05912-0 
47.  Born KB, Coulter A, Han A, et al. Engaging patients and the public in Choosing Wisely. BMJ Qual 
Saf. 2017;26(8):687-691. doi:10.1136/bmjqs-2017-006595 
48.  Morley J, Cowls J, Taddeo M, Floridi L. Public Health in the Information Age: Recognizing the 
Infosphere as a Social Determinant of Health. Journal of Medical Internet Research. 
2020;22(8):e19311. doi:10.2196/19311 
49.  Suarez-Lledo V, Alvarez-Galvez J. Prevalence of Health Misinformation on Social Media: 
Systematic Review. Journal of medical Internet research. 2021;23(1):e17187. 
doi:http://dx.doi.org.ezproxy.lib.uts.edu.au/10.2196/17187 
50.  Bourne T, Wynants L, Peters M, et al. The impact of complaints procedures on the welfare, 
health and clinical practise of 7926 doctors in the UK: a cross-sectional survey. BMJ Open. 
2015;5(1):e006687-e006687. doi:10.1136/bmjopen-2014-006687 
51.  Kaldjian LC. Communication about medical errors. Patient Education and Counseling. 
2021;104(5):989-993. doi:10.1016/j.pec.2020.11.035 
52.  Dael J van, Reader TW, Gillespie A, Neves AL, Darzi A, Mayer EK. Learning from complaints in 
healthcare: a realist review of academic literature, policy evidence and front-line insights. BMJ 
Qual Saf. 2020;29(8):684-695. doi:10.1136/bmjqs-2019-009704 
53.  Myren BJ, Hullu JA de, Bastiaans S, Koksma JJ, Hermens RPMG, Zusterzeel PLM. Disclosing 
Adverse Events in Clinical Practice: The Delicate Act of Being Open. Health Communication. 
2020;0(0):1-11. doi:10.1080/10410236.2020.1830550 
54.  Allan A, McKillop D, Dooley J, Allan MM, Preece DA. Apologies following an adverse medical 
event: The importance of focusing on the consumer’s needs. Patient Education and Counseling. 
2015;98(9):1058-1062. doi:10.1016/j.pec.2015.06.001 
55.  Sattar R, Johnson J, Lawton R. The views and experiences of patients and health-care 
professionals on the disclosure of adverse events: A systematic review and qualitative meta-
ethnographic synthesis. Health Expectations. 2020;23(3):571-583. doi:10.1111/hex.13029 
56.  Vasileiou K, Barnett J, Thorpe S, Young T. Characterising and justifying sample size sufficiency in 
interview-based studies: systematic analysis of qualitative health research over a 15-year 
period. BMC Medical Research Methodology. 2018;18(1):148. doi:10.1186/s12874-018-0594-7 
57.  McCarron TL, Clement F, Rasiah J, et al. Patients as partners in health research: A scoping 
review. Health Expectations. 2021;24(4):1378-1390. doi:10.1111/hex.13272 
58.  Brownlee S, Chalkidou K, Doust J, et al. Evidence for overuse of medical services around the 





59.  Ali AA, Hummeida ME, Elhassan YAM, M.Nabag WO, Ahmed MAA, Adam GK. Concept of 
defensive medicine and litigation among Sudanese doctors working in obstetrics and 
gynecology. BMC Med Ethics. 2016;17(1):12. doi:10.1186/s12910-016-0095-3 
60.  Sheridan S, Hatlie M. We’re Not Your Enemy: An Appeal from a Consumer to Re-imagine Tort 
Reform. Patient Safety & Quality Healthcare. 2007;4:22-26. 
 
 
 
 
 
